KOD FY2021 SEC EDGAR DEF 14A

Kodiak Sciences Inc. CEO pay ratio

The CEO earned $113.4M in FY2021 against median worker pay of $1,667,224 · Chemicals & Pharmaceuticals.

State
DE
Filing date
2022-04-28
Industry
Chemicals & Pharmaceuticals
Fiscal year
FY2021

Data updated August 2026

Subscribe to Kodiak Sciences Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
68:1
Moderate (Scale: 0–1000:1)
CEO pay
$113.4M
Median worker
$1,667,224

Latest filing FY2021. This company's newest DEF 14A on file is for FY2021, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.

Answer first

Kodiak Sciences Inc. reported a 68:1 CEO-to-worker pay ratio in FY2021 - above the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.

Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Pay ratio
68:1
FY2021 disclosed
CEO total
$113.4M
Summary Compensation Table total
Median worker
$1,667,224
Dodd-Frank median employee

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2021

A component-level pay breakdown is not reported in Kodiak Sciences Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
68:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$113.4M
Companies in Industry
168
vs. Industry Median
Above

Kodiak Sciences Inc.: MODEST · OUTLIER pay ratio

Kodiak Sciences Inc. disclosed 68:1 CEO-to-worker pay and $113.4M CEO total in FY2021. the CEO earned 68× the median employee ($1,667,224) in FY2021.

Median employee $1,667,224 (ELITE-MED); MODEST · OUTLIER stamps put about 68 median-wage years per CEO year.

CEO Total Pay

$113.4M

FY2021 Summary Compensation, well above median

Pay Ratio

68:1

Near industry median

What FY2021 shows for Kodiak Sciences Inc.

Kodiak Sciences Inc. disclosed 68:1 CEO-to-worker pay and $113.4M CEO total in FY2021. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Kodiak Sciences Inc.'s $113.4M CEO total is above the $7.9M industry median CEO pay.

Kodiak Sciences Inc. stamps MODEST · OUTLIER · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2021

Total Compensation
$113.4M
Median Employee Pay
$1,667,224
Pay Ratio
68:1
Filing Date
2022-04-28

Company Info

Ticker
KOD
CIK
1468748
Industry
Chemicals & Pharmaceuticals
SIC Code
2836
State
DE
SEC EDGAR DEF 14A for CIK 1468748, FY2021. Informational only, not investment advice. Verify on EDGAR.

Read with Kodiak Sciences Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · OUTLIER · ELITE-MED.

Data sourced from SEC EDGAR DEF 14A for Kodiak Sciences Inc. (CIK 1468748), FY2021. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.